Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-11,575
Closed -$92K 1154
2021
Q3
$92K Hold
11,575
﹤0.01% 434
2021
Q2
$86.7K Hold
11,575
﹤0.01% 463
2021
Q1
$70K Sell
11,575
-725
-6% -$5.58K ﹤0.01% 482
2020
Q4
$70.2K Buy
12,300
+6,000
+95% +$38.2K ﹤0.01% 444
2020
Q3
$41.9K Sell
6,300
-6,475
-51% -$57.7K ﹤0.01% 500
2020
Q2
$113K Buy
12,775
+6,475
+103% +$18.6K 0.01% 307
2020
Q1
$11.2K Buy
6,300
+5,599
+799% +$7.13K ﹤0.01% 683
2019
Q4
$246 Hold
701
﹤0.01% 1021
2019
Q3
$252 Hold
701
﹤0.01% 1022
2019
Q2
$470 Hold
701
﹤0.01% 1031
2019
Q1
$1.36K Hold
701
﹤0.01% 1011
2018
Q4
$1.32K Hold
701
﹤0.01% 1017
2018
Q3
$2K Hold
701
﹤0.01% 1045
2018
Q2
$2.12K Hold
701
﹤0.01% 1052
2018
Q1
$3.73K Sell
701
-2
-0.3% -$13 ﹤0.01% 997
2017
Q4
$4.38K Sell
703
-1,184
-63% -$8.27K ﹤0.01% 978
2017
Q3
$14.2K Buy
+1,887
New +$12.8K ﹤0.01% 762

Other funds holding VXRT

RBC Europe's VXRT Position: Q4 2021 in Review

RBC Europe sold out of Vaxart (VXRT) in Q4 2021, closing a stake of 11,575 shares — an estimated $92K sold.

RBC Europe first reported a position in VXRT in Q3 2017 and held it in 17 quarters. The position peaked at $113K in Q2 2020. 147 funds tracked by Wall St. Rank hold VXRT as of Q4 2021.

  • RBC Europe reported no remaining Vaxart position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 11,575 Vaxart shares in Q4 2021, an estimated $92K.
  • RBC Europe first reported a position in Vaxart in Q3 2017 and held it in 17 quarters.
  • RBC Europe's Vaxart position peaked at $113K in Q2 2020.
  • 147 funds tracked by Wall St. Rank held Vaxart as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.